Robert Stone

Robert Stone

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
Healthcare
View Bio
RSS

Latest Posts › HRSA

Share:

Health Care Week in Review: HRSA Issues Requests For Proposals As Part Of Initiative To Reform The Organ Transplant System;...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/12/2024  /  Biologics , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , HRSA , Organ Transplant Centers

Health Care Week in Review: CMS Publishes Medicate Advantage Advance Notice and Senate Publishes Draft 340B Legislation

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/5/2024  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Workers , HRSA , Medicaid , Medicare

Health Care Week in Review: CMS Announces Data RFI to Improve Medicare Advantage Transparency; Senate Finance Committee Releases...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

1/29/2024  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Generic Drugs , Health Care Providers , Healthcare Facilities , Hospitals , HRSA , Medicaid , Medicare , Medicare Advantage , National Institute of Health (NIH) , Request For Information

Health Care Week In Review: HRSA Releases List of Health Professional Shortage Areas, Biden Bolsters HHS Authority to Address Drug...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

1/8/2024  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Life Sciences , Medicaid , Medicare , National Institute of Health (NIH) , Prescription Drugs , SAMHSA

Health Care Week In Review: House Passes the SUPPORT Act and Lower Cost, More Transparency Act, HHS Releases Final Rule on Health...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/18/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medicare , Pharmaceutical Industry , Prescription Drugs

Health Care Week in Review: Biden Signs “Laddered” Continuing Resolution; House E&C Subcommittee Advances 21 Healthcare Bills

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/20/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medicare , Prescription Drugs

Health Care Week in Review: New House Speaker Elected; HRSA Issued a Notice on 340B Drug Pricing Program Requirements

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/30/2023  /  Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , DEA , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , HRSA , Medicaid , Medicare , Pharmaceutical Industry , Popular , Prescription Drugs , Section 340B

Health Care Week in Review: House Energy and Commerce Subcommittee on Health Held Hearing on Medicare Proposals, CMS Released 2024...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/23/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicare , Medicare Part D , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs

Health Care Week in Review: Government Shutdown in Sight, CBO Releases Report on CMMI’s Effect on Federal Spending

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/2/2023  /  Centers for Medicare & Medicaid Services (CMS) , Cybersecurity , Department of Health and Human Services (HHS) , Food Allergies , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medical Devices , Mental Health , National Institute of Health (NIH) , Pharmaceutical Patents , Prescription Drugs

Health Care Week in Review: CMS Issues Final Rule on Medicare Savings Program, Senate Considers Primary Care and Healthcare...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/25/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Workers , HRSA , Medicare , Prescription Drugs , SAMHSA

Health Care Week In Review: Lower Cost, More Transparency Act Draft Health Bill Released

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/11/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , HRSA , National Institute of Health (NIH) , Nursing Homes , OIG

Health Care Week in Review: CMS Announces Details to Pay Drug Costs on Installment Plan

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/29/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicare , Medicare Part D , Pharmaceutical Industry , Popular , Prescription Drugs , Vaccinations

Health Care Week in Review: Leqembi Approval, Administration Issues Proposed Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/10/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Insurance , HRSA , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , Prescription Drugs , Section 340B

Health Care Week In Review: Fifth Circuit Review of ACA Requirement and HRSA Funds Health Centers

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/22/2023  /  Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Mental Health , Nursing Homes , Popular , Public Health Emergency

Health Care Week In Review: COVID-19 PHE Expires, DEA Issues Final Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/15/2023  /  Biologics , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Coronavirus/COVID-19 , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Popular , Prescription Drugs , Public Health Emergency , Telehealth , Telemedicine

Health Care Week In Review: Surgeon General Advisory on Loneliness and EMTALA Requirements

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/8/2023  /  Biosimilars , Centers for Disease Control and Prevention (CDC) , Clinical Trials , Department of Health and Human Services (HHS) , EMTALA , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medical Devices , National Institute of Health (NIH) , Popular , SAMHSA

Health Care Week in Review: Health Care Budget Hearings and Organ System Modernization

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/27/2023  /  Centers for Disease Control and Prevention (CDC) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medicare , SAMHSA

Health Care Week in Review: President’s Budget and ASPR Cybersecurity Guide

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/13/2023  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Cybersecurity , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , Popular , Public Health , Public Health Emergency

Health Care Week in Review: DEA Issues Proposed Rules on Controlled Substances Prescribing via Telemedicine

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/7/2023  /  Controlled Substances , DEA , Department of Health and Human Services (HHS) , Electronic Prescribing , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , Telehealth , Telemedicine

HHS Announces $20 Billion Phase 3 General Distribution

Our Health Care Group reviews the nuances for eligibility and applying for the latest round of COVID-19 relief from the CARES Act’s Provider Relief Fund....more

10/5/2020  /  CARES Act , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , HRSA , Provider Relief Fund , Reporting Requirements
45 Results
 / 
View per page
« Previous
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide